LOCKHEED MARTIN CORPORATION (NYSE: LMT) INVESTOR ALERT Investors With Large Losses in Lockheed Martin Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights — Neutral
LMT GlobeNewsWire — July 30, 2025NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Lockheed Martin Corporation (“Lockheed Martin” or the “Company”) (NYSE: LMT) between January 23 , 202 4 and July 21 , 202 5, inclusive. For more information, submit a form at Lockheed Martin Corporation Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030.
Prologis to Develop Largest Rooftop Community Solar Portfolio in Northern Illinois — Neutral
EXC Business Wire — July 30, 2025CHICAGO--(BUSINESS WIRE)--ComEd today joined Prologis, a global development company, in marking the launch of a rooftop community solar project in Franklin Park, the first of 45 installations that the global logistics firm is developing across Illinois over the next two years. The Prologis portfolio is expected to generate 82 megawatts (MW) of solar energy, resulting in the largest rooftop community solar initiative in northern Illinois. More than half of the energy credits will be directed to.
IDEX Corporation (NYSE:IEX ) Q2 2025 Earnings Conference Call July 30, 2025 9:00 AM ET Company Participants Akhil Mahendra - Interim CFO & VP of Corporate Development Eric D. Ashleman - CEO, President & Director Jim Giannakouros - Corporate Participant Conference Call Participants Andrew Edouard Buscaglia - BNP Paribas Exane, Research Division Brett Logan Linzey - Mizuho Securities USA LLC, Research Division Bryan Francis Blair - Oppenheimer & Co. Inc., Research Division Deane Michael Dray - RBC Capital Markets, Research Division Jeffrey Todd Sprague - Vertical Research Partners, LLC Joseph Craig Giordano - TD Cowen, Research Division Matt J.
Strategic Education, Inc. (STRA) Q2 2025 Earnings Call Transcript — Neutral
STRA Seeking Alpha — July 30, 2025Strategic Education, Inc. (NASDAQ:STRA ) Q2 2025 Earnings Conference Call July 30, 2025 10:00 AM ET Company Participants Karl McDonnell - President, CEO & Director Terese Wilke - Director of Investor Relations Conference Call Participants Alexander Peter Paris - Barrington Research Associates, Inc., Research Division Jasper James Bibb - Truist Securities, Inc., Research Division Jeffrey Marc Silber - BMO Capital Markets Equity Research Operator Hello, and welcome to Strategic Education's Second Quarter 2025 Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
SunCoke Energy, Inc. Q2 2025 Earnings Conference Call July 30, 2025 11:00 AM ET Company Participants Katherine T. Gates - CEO, President & Director Mark W.
Ares Capital Q2 Earnings Miss Estimates as Expenses Rise Y/Y — Negative
ARCC Zacks Investment Research — July 30, 2025ARCC's Q2 earnings slip 18% y/y as investment income declines and rising fees push total expenses up 11%.
Illinois Tool Tops Q2 Earnings Estimates, Raises 2025 View — Positive
ITW Zacks Investment Research — July 30, 2025ITW tops Q2 estimates and lifts 2025 guidance as strong margins and segment gains offset flat organic sales.
Here's What Investors Must Know Ahead of Quanta's Q2 Earnings — Positive
PWR Zacks Investment Research — July 30, 2025PWR's infrastructure momentum powers 17% revenue growth forecast for Q2, but margin headwinds may test earnings resilience.
American Vanguard Announces Date of Second Quarter 2025 Earnings Release and Webcast Conference Call — Neutral
AVD Business Wire — July 30, 2025NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard® Corporation (NYSE: AVD) announced today it will release financial results for the second quarter of 2025 on Thursday, July 31, 2025, after the market closes. The company will conduct a conference call focusing on operating performance and financial results at 5:00 p.m. ET / 2:00 p.m. PT on Thursday, July 31, 2025. The conference call will be webcast live, available in the Investors section of the Company's website at www.american-vangua.
IR Gears Up to Post Q2 Earnings: What Lies Ahead for the Stock? — Neutral
IR Zacks Investment Research — July 30, 2025Ingersoll Rand's Q2 results face pressure from higher costs, but segment gains and recent acquisitions may help offset headwinds.
Sanmina Q3 Earnings Surpass Estimates, Revenues Rise Y/Y — Positive
SANM Zacks Investment Research — July 30, 2025SANM posts strong fiscal Q3 results with EPS and revenues beats, fueled by growth across end markets and surging free cash flow.
Materion (MTRN) Q2 Earnings and Revenues Top Estimates — Positive
MTRN Zacks Investment Research — July 30, 2025Materion (MTRN) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.18 per share. This compares to earnings of $1.42 per share a year ago.
Live Earnings: Will TransMedics (TMDX) Rally After Earnings? — Neutral
TMDX 24/7 Wall Street — July 30, 2025TransMedics Group reports its Q2 earnings after the bell. Wall Street current expectations stand at: Revenue: $147.74 million Adjusted EPS: $.43 We'll be updating this live blog with updates during the trading day and then once earnings hit the newswires will post a flurry of news and analysis.
Materion Corporation (MTRN) Q2 2025 Earnings Call Transcript — Neutral
MTRN Seeking Alpha — July 30, 2025Materion Corporation (NYSE:MTRN ) Q2 2025 Earnings Conference Call July 30, 2025 10:00 AM ET Company Participants Jugal K. Vijayvargiya - CEO, President & Director Kyle Kelleher - Director of Investor Relations & Corporate FP&A Shelly M.
West Pharmaceutical Services, Inc.'s Q2 results signal a return to growth, driven by strong demand for high-value products and GLP-1 agonist components. I am revamping my bullish thesis: GLP-1 drugs now provide a powerful, sustained growth catalyst beyond the company's traditional biologics and injectable therapeutics exposure. Risks include elevated valuation, potential competition, and the threat of oral GLP-1 formulations or healthcare policy changes impacting future growth.
Robinhood heads into earnings on Wall Street hot streak — Positive
HOOD CNBC Television — July 30, 2025CNBC's MacKenzie Sigalos reports on Robinhood's 177% surge this year and how its expansion into global fintech, tokenized stocks, and crypto infrastructure is fueling investor focus ahead of earnings.
Industrial Logistics Properties Trust (ILPT) Q2 2025 Earnings Call Transcript — Neutral
ILPT Seeking Alpha — July 30, 2025Industrial Logistics Properties Trust (NASDAQ:ILPT ) Q2 2025 Earnings Conference Call July 30, 2025 10:00 AM ET Company Participants Marc Krohn - Vice President Matt Murphy - Manager of Investor Relations Tiffany R. Sy - CFO & Treasurer Yael Duffy - President & COO Conference Call Participants John James Massocca - B.
Expand Energy Corporation (EXE) Q2 2025 Earnings Call Transcript — Neutral
EXE Seeking Alpha — July 30, 2025Expand Energy Corporation (NASDAQ:EXE ) Q2 2025 Earnings Conference Call July 30, 2025 9:00 AM ET Company Participants & - Corporate Participant Chris Ayres - Vice President of Investor Relations & Special Projects Daniel F. Turco - Executive Vice President of Marketing Commercial Domenic J.
Clarivate Plc (NYSE:CLVT ) Q2 2025 Earnings Conference Call July 30, 2025 9:00 AM ET Company Participants Jonathan M. Collins - Executive VP & CFO Mark J.
Cimpress Q4 Earnings Miss Estimates, Revenue Increase Y/Y — Negative
CMPR Zacks Investment Research — July 30, 2025CMPR posts Q4 revenue beat with 4.4% growth, but swings to a $1.02 loss per share vs. $4.33 EPS a year ago.